Chemoinformaics analysis of 3,5-Dimethoxytoluene
| Molecular Weight | 152.193 | nRot | 2 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 16 |
| Exact Molecular Weight | 152.084 | nRing | 1 |
| Solubility: LogS | -1.964 | nHRing | 0 |
| Solubility: LogP | 0.664 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.6355 |
| nHD | 0 | BPOL | 15.5105 |
| QED | 0.395 |
| Synth | 4.847 |
| Natural Product Likeliness | 3.336 |
| NR-PPAR-gamma | 0.851 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.931 |
| CACO-2 | -4.835 |
| MDCK | 0.0000252 |
| BBB | 0.87 |
| PPB | 0.572896 |
| VDSS | 1.343 |
| FU | 0.232702 |
| CYP1A2-inh | 0.123 |
| CYP1A2-sub | 0.147 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.508 |
| CYP2c9-inh | 0.061 |
| CYP2c9-sub | 0.644 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.236 |
| CL | 3.551 |
| T12 | 0.371 |
| hERG | 0.005 |
| Ames | 0.074 |
| ROA | 0.787 |
| SkinSen | 0.113 |
| Carcinogencity | 0.113 |
| EI | 0.025 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.126 |
| Antiviral | No |
| Prediction | 0.907522 |